INFUSYSTEM HOLDINGS, INC Net Cash Provided by (Used in) Investing Activities, Continuing Operations
INFUSYSTEM HOLDINGS, INC (INFU) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $689.00 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-11-13
- INFUSYSTEM HOLDINGS, INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$41.00K, a 106.08% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $220.00K.
- INFUSYSTEM HOLDINGS, INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $510.00K.
- INFUSYSTEM HOLDINGS, INC net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$658.00K, a 184.04% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$5.34M.
- INFUSYSTEM HOLDINGS, INC net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$11.91M.
- INFUSYSTEM HOLDINGS, INC net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$2.84M.
- INFUSYSTEM HOLDINGS, INC net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$2.16M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-09-30 | -$41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $179.00K derived: sum of 2 quarters · filed 2017-11-13 | $689.00K 10-Q · filed 2017-11-13 | $31.00K derived: sum of 4 quarters · filed 2017-11-13 |
| 2017-06-30 | $220.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $730.00K 10-Q · filed 2017-08-09 | $72.00K derived: sum of 3 quarters · filed 2017-08-09 | $746.00K derived: sum of 4 quarters · filed 2017-11-13 |
| 2017-03-31 | $510.00K 10-Q · filed 2017-05-15 | -$148.00K derived: sum of 2 quarters · filed 2017-05-15 | $526.00K derived: sum of 3 quarters · filed 2017-11-13 | -$2.44M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-12-31 | -$658.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | $16.00K derived: sum of 2 quarters · filed 2017-11-13 | -$2.95M derived: sum of 3 quarters · filed 2017-11-13 | -$5.34M 10-K · filed 2017-03-22 |
| 2016-09-30 | $674.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$2.30M derived: sum of 2 quarters · filed 2017-11-13 | -$4.69M 10-Q · filed 2017-11-13 | -$3.90M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | -$2.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$5.36M 10-Q · filed 2017-08-09 | -$4.58M derived: sum of 3 quarters · filed 2017-08-09 | -$5.88M derived: sum of 4 quarters · filed 2017-08-09 |
| 2016-03-31 | -$2.39M 10-Q · filed 2017-05-15 | -$1.61M derived: sum of 2 quarters · filed 2017-05-15 | -$2.91M derived: sum of 3 quarters · filed 2017-05-15 | -$11.74M derived: sum of 4 quarters · filed 2017-05-15 |
| 2015-12-31 | $783.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | -$523.00K derived: sum of 2 quarters · filed 2017-03-22 | -$9.36M derived: sum of 3 quarters · filed 2017-03-22 | -$11.91M 10-K · filed 2017-03-22 |
| 2015-09-30 | -$1.31M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-12-12 | -$10.14M derived: sum of 2 quarters · filed 2016-12-12 | -$12.69M 10-Q · filed 2016-12-12 | -$13.55M derived: sum of 4 quarters · filed 2016-12-12 |
| 2015-06-30 | -$8.83M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2016-12-12 | -$11.38M 10-Q/A · filed 2016-12-12 | -$12.25M derived: sum of 3 quarters · filed 2016-12-12 | -$13.70M derived: sum of 4 quarters · filed 2016-12-12 |
| 2015-03-31 | -$2.55M 10-Q/A · filed 2016-12-12 | -$3.42M derived: sum of 2 quarters · filed 2016-12-12 | -$4.87M derived: sum of 3 quarters · filed 2016-12-12 | -$5.51M derived: sum of 4 quarters · filed 2016-12-12 |
| 2014-12-31 | -$863.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-12-12 | -$2.32M derived: sum of 2 quarters · filed 2016-12-12 | -$2.96M derived: sum of 3 quarters · filed 2016-12-12 | -$2.84M 10-K/A · filed 2016-12-12 |
| 2014-09-30 | -$1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$2.10M derived: sum of 2 quarters · filed 2015-11-12 | -$1.98M 10-Q · filed 2015-11-12 | -$3.55M derived: sum of 4 quarters · filed 2015-11-12 |
| 2014-06-30 | -$644.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$519.00K 10-Q · filed 2015-08-13 | -$2.09M derived: sum of 3 quarters · filed 2015-08-13 | -$1.84M derived: sum of 4 quarters · filed 2015-08-13 |
| 2014-03-31 | $125.00K 10-Q · filed 2015-05-12 | -$1.45M derived: sum of 2 quarters · filed 2015-05-12 | -$1.20M derived: sum of 3 quarters · filed 2015-05-12 | -$1.35M derived: sum of 4 quarters · filed 2015-05-12 |
| 2013-12-31 | -$1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | -$1.32M derived: sum of 2 quarters · filed 2015-03-09 | -$1.48M derived: sum of 3 quarters · filed 2015-03-09 | -$2.16M 10-K · filed 2015-03-09 |
| 2013-09-30 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $96.00K derived: sum of 2 quarters · filed 2014-11-10 | -$588.00K 10-Q · filed 2014-11-10 | |
| 2013-06-30 | -$154.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | -$838.00K 10-Q · filed 2014-08-01 | ||
| 2013-03-31 | -$684.00K 10-Q · filed 2014-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |